{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "from nltk.tokenize import sent_tokenize\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.stem import PorterStemmer\n",
    "import matplotlib.pyplot as plt\n",
    "from nltk.corpus import stopwords"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.6/lib/python3.6/site-packages/IPython/core/interactiveshell.py:3063: DtypeWarning: Columns (5,13,14,16) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  interactivity=interactivity, compiler=compiler, result=result)\n"
     ]
    }
   ],
   "source": [
    "#Reading in Metadata\n",
    "df =  pd.read_csv(\"/Users/MattNwerem/Downloads/COVID_Kaggle_CORD-19/metadata.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            118\n",
       "An amendment to this paper has been published and can be accessed via a link at the top of the paper.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               38\n",
       "[Figure: see text]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  28\n",
       "[Figure: see text].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 12\n",
       "A roundup of the latest nursing news.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               11\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ... \n",
       "AIMS Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in high-risk patients with non-valvular atrial fibrillation. The objective of the multicentre EWOLUTION registry was to obtain clinical data on procedural success and complications, and long-term patient outcomes, including bleeding and incidence of stroke/transient ischaemic attack (TIA). Here, we report on the peri-procedural outcomes of up to 30 days. METHODS AND RESULTS Baseline/implant data are available for 1021 subjects. Subjects in the study were at high risk of stroke (average CHADS2 score: 2.8 ± 1.3, CHA2DS2-VASc: 4.5 ± 1.6) and moderate-to-high risk of bleeding (average HAS-BLED score: 2.3 ± 1.2). Almost half of the subjects (45.4%) had a history of TIA, ischaemic stroke, or haemorrhagic stroke; 62% of patients were deemed unsuitable for novel oral anticoagulant by their physician. The device was successfully deployed in 98.5% of patients with no flow or minimal residual flow achieved in 99.3% of implanted patients. Twenty-eight subjects experienced 31 serious adverse events (SAEs) within 1 day of the procedure. The overall 30-day mortality rate was 0.7%. The most common SAE occurring within 30 days of the procedure was major bleeding requiring transfusion. Incidence of SAEs within 30 days was significantly lower for subjects deemed to be ineligible for oral anticoagulation therapy (OAT) compared with those eligible for OAT (6.5 vs. 10.2%, P = 0.042). CONCLUSION Left atrial appendage closure with the WATCHMAN device has a high success rate in complete LAAC with low peri-procedural risk, even in a population with a higher risk of stroke and bleeding, and multiple co-morbidities. Improvement in implantation techniques has led to a reduction of peri-procedural complications previously limiting the net clinical benefit of the procedure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1\n",
       "The water soluble green tea polyphenol epigallocatechin gallate (EGCG) was lipophilised by esterification with different fatty acids for expanded applications. Four lipophilic ester derivatives of EGCG, namely EGCG-O-tetrastearate, EGCG-O-tetraeicosapentaenoate, EGCG-O-tetradocosahexaenoate, and EGCG-O-octabutyrate, were prepared and evaluated for their antioxidant and antiviral activities in vitro. Incorporation of fatty acids, especially the long chain polyunsaturated fatty acids (PUFA), into EGCG resulted in increased peroxyl radical scavenging activity, as measured by ORAC (oxygen radical absorbance capacity) assay, and metal chelation capacity. However, the esters exhibited decreased reducing power. Antiviral activities of EGCG derivatives were remarkably higher than the parent EGCG molecule, which showed relatively weak effects. The EGCG–PUFA esters were 1700-fold more effective in inhibiting hepatitis C virus (HCV) protease than the positive control embelin. The derivatives also acted as α-glucosidase inhibitors, suggesting their potential in anti-HIV (human immunodeficiency virus) treatment. The results suggest that ester derivatives of EGCG with improved bioactivities may serve as excellent functional food ingredients and natural health products. Moreover, the omega-3 PUFA in the derivatives may also render additional or synergistic health benefits.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "BACKGROUND: Lactate dehydrogenase-elevating virus (LDV) is a natural infectious agent of mice. Like several other viruses, LDV causes widespread and very rapid but transient activation of both B cells and T cells in lymphoid tissues and the blood. The mechanism of this activation has not been fully described and is the focus of the current studies. PRINCIPAL FINDINGS: A known inducer of early lymphocyte activation is IFNα, a cytokine strongly induced by LDV infection. Neutralization of IFNα in the plasma from infected mice ablated its ability to activate lymphocytes in vitro. Since the primary source of virus-induced IFNα in vivo is often plasmacytoid dendritic cells (pDC's), we depleted these cells prior to LDV infection and tested for lymphocyte activation. Depletion of pDC's in vivo eradicated both the LDV-induced IFNα response and lymphocyte activation. A primary receptor in pDC's for single stranded RNA viruses such as LDV is the toll-like receptor 7 (TLR7) pattern recognition receptor. Infection of TLR7-knockout mice revealed that both the IFNα response and lymphocyte activation were dependent on TLR7 signaling in vivo. Interestingly, virus levels in both TLR7 knockout mice and pDC-depleted mice were indistinguishable from controls indicating that LDV is largely resistant to the systemic IFNα response. CONCLUSION: Results indicate that LDV-induced activation of lymphocytes is due to recognition of LDV nucleic acid by TLR7 pattern recognition receptors in pDC's that respond with a lymphocyte-inducing IFNα response.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1\n",
       "Abstract Background During the COVID-19 pandemic, several acral chilblain-like skin lesions (CBLL) were observed in young patients with suspected, but mostly unconfirmed, infection with SARS-CoV-2. The histopathological aspect of these lesions is as yet poorly known. Objective To investigate the pathologic features of CBLL. Methods Biopsies were obtained from 17 cases of CBLL during the COVID-19 pandemic in France and were studied by routine histological examination, immunohistochemistry and direct immunofluorescence (DIF). The patients had suspected but unconfirmed infection with SARS-CoV-2 (negative nasopharyngeal PCR test and serological tests). Results CBLL showed many features with those reported in idiopathic (IC) and auto-immune related chilblains (AC), including epidermal necrotic keratinocytes, dermal edema, perivascular and perieccrine sweat gland lymphocytic (predominantly CD3/CD4+) inflammation and frequent vascular changes (endothelialitis, microthromboses, fibrin deposition, immunoreactant deposits on vessels). Conclusions CBLL show similar histopathologic features with IC and AC, with a rather high rate of vascular changes and DIF positivity. The role of SARS-CoV-2 in the development of these puzzling lesions remains to be elucidated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1\n",
       "This thesis contains four studies all focusing on women with endometrial cancer undergoing robotic-assisted laparoscopic hysterectomy (RALH). Women with endometrial cancer are typically elderly with co-morbidities. RALH is a relatively new treatment option which has been introduced and adopted over the last decade without randomised controlled trials (RCTs) to prove superiority over other surgical alternatives. The purpose of the thesis was to explore and describe patient and health economic outcomes of RALH for women with endometrial cancer using different research approaches. The first study was a retrospective descriptive cohort study with 235 women. The aim was to explore types and incidence of post-operative complications within 12 months after RALH reported with the Clavien-Dindo scale. We found that 6% had severe complications and that women with lymphadenectomy did not have an increased rate of complications. Urinary tract and port site infections were the most frequent complications. The second study was a qualitative interview study where we explored the experience of undergoing RALH. Using content analysis, we analysed semi-structured interviews with 12 women who had undergone RALH on average 12 weeks earlier. The women were positive towards the robotic approach and felt recovered shortly after. They expressed uncertainty with the normal course of bleeding and bowel movement post-operatively as well as with the new anatomy. The third study was an economic evaluation; an activity-based costing study including 360 women comparing total abdominal hysterectomy (TAH) to RALH. This study showed that for women with endometrial cancer, RALH was cheaper compared to TAH, mainly due to fewer complications and shorter length of stay (LOS) that counterbalanced the higher robotic expenses. When including all cost drivers the analysis showed that the RALH procedure was more than 9.000 Danish kroner (DKK) cheaper than the TAH. Increased age and Type 2 diabetes appeared to increase costs. The fourth study was a prospective cohort study of 139 women who were followed four months after surgery with the aim to assess short term changes in health-related quality of life (HRQoL), symptoms and function after RALH. Both a general and an illness specific HRQoL questionnaire were used. The preoperative baseline measurement was compared with measurements at one and five weeks and four months post-operatively. The women also selfreported their level of activity once a week for the first five weeks after surgery. We found that HRQoL was back to baseline level at five weeks post-operatively for the majority of women. Fatigue, constipation, gastrointestinal symptoms, pain, appetite and change of taste were negatively affected short-term. At five weeks the mean level of physical activity resumed was 84%. Together, the studies indicate that RALH is a well-tolerated surgical treatment for women with endometrial cancer, and post-operative complications appear fewer and less severe compared to previous open surgery. This points towards RALH being clinically and economically efficient. The women experienced that RALH was easy to overcome and they felt recovered shortly after. However, they expressed uncertainty about the normal post-operative cause and reported changes in functions and symptoms short term after surgery. These changes should be addressed in the preoperative information and at the post-operative follow-up. It is difficult imagining a RCT of robotic-assisted laparoscopic hysterectomy being conducted in the future due to reluctance towards randomisation to open surgery. However, it would be advisable continuously to monitor relevant surgical and patient-reported outcomes as indications for robotic surgery may alter, experiences may develop and further technical advances may change robotic surgery for women with endometrial cancer in the future.      1\n",
       "Name: abstract, Length: 111027, dtype: int64"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Just peeking to see what I get with value_counts()\n",
    "df[\"abstract\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cord_uid</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>mag_id</th>\n",
       "      <th>who_covidence_id</th>\n",
       "      <th>arxiv_id</th>\n",
       "      <th>pdf_json_files</th>\n",
       "      <th>pmc_json_files</th>\n",
       "      <th>url</th>\n",
       "      <th>s2_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ug7v899j</td>\n",
       "      <td>d1aafb70c066a2068b02786f8929fd9c900897fb</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Clinical features of culture-proven Mycoplasma...</td>\n",
       "      <td>10.1186/1471-2334-1-6</td>\n",
       "      <td>PMC35282</td>\n",
       "      <td>11472636.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>OBJECTIVE: This retrospective chart review des...</td>\n",
       "      <td>2001-07-04</td>\n",
       "      <td>Madani, Tariq A; Al-Ghamdi, Aisha A</td>\n",
       "      <td>BMC Infect Dis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>document_parses/pdf_json/d1aafb70c066a2068b027...</td>\n",
       "      <td>document_parses/pmc_json/PMC35282.xml.json</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>02tnwd4m</td>\n",
       "      <td>6b0567729c2143a66d737eb0a2f63f2dce2e5a7d</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Nitric oxide: a pro-inflammatory mediator in l...</td>\n",
       "      <td>10.1186/rr14</td>\n",
       "      <td>PMC59543</td>\n",
       "      <td>11667967.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>Inflammatory diseases of the respiratory tract...</td>\n",
       "      <td>2000-08-15</td>\n",
       "      <td>Vliet, Albert van der; Eiserich, Jason P; Cros...</td>\n",
       "      <td>Respir Res</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>document_parses/pdf_json/6b0567729c2143a66d737...</td>\n",
       "      <td>document_parses/pmc_json/PMC59543.xml.json</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ejv2xln0</td>\n",
       "      <td>06ced00a5fc04215949aa72528f2eeaae1d58927</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Surfactant protein-D and pulmonary host defense</td>\n",
       "      <td>10.1186/rr19</td>\n",
       "      <td>PMC59549</td>\n",
       "      <td>11667972.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>Surfactant protein-D (SP-D) participates in th...</td>\n",
       "      <td>2000-08-25</td>\n",
       "      <td>Crouch, Erika C</td>\n",
       "      <td>Respir Res</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>document_parses/pdf_json/06ced00a5fc04215949aa...</td>\n",
       "      <td>document_parses/pmc_json/PMC59549.xml.json</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2b73a28n</td>\n",
       "      <td>348055649b6b8cf2b9a376498df9bf41f7123605</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Role of endothelin-1 in lung disease</td>\n",
       "      <td>10.1186/rr44</td>\n",
       "      <td>PMC59574</td>\n",
       "      <td>11686871.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>Endothelin-1 (ET-1) is a 21 amino acid peptide...</td>\n",
       "      <td>2001-02-22</td>\n",
       "      <td>Fagan, Karen A; McMurtry, Ivan F; Rodman, David M</td>\n",
       "      <td>Respir Res</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>document_parses/pdf_json/348055649b6b8cf2b9a37...</td>\n",
       "      <td>document_parses/pmc_json/PMC59574.xml.json</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9785vg6d</td>\n",
       "      <td>5f48792a5fa08bed9f56016f4981ae2ca6031b32</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Gene expression in epithelial cells in respons...</td>\n",
       "      <td>10.1186/rr61</td>\n",
       "      <td>PMC59580</td>\n",
       "      <td>11686888.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>Respiratory syncytial virus (RSV) and pneumoni...</td>\n",
       "      <td>2001-05-11</td>\n",
       "      <td>Domachowske, Joseph B; Bonville, Cynthia A; Ro...</td>\n",
       "      <td>Respir Res</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>document_parses/pdf_json/5f48792a5fa08bed9f560...</td>\n",
       "      <td>document_parses/pmc_json/PMC59580.xml.json</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   cord_uid                                       sha source_x  \\\n",
       "0  ug7v899j  d1aafb70c066a2068b02786f8929fd9c900897fb      PMC   \n",
       "1  02tnwd4m  6b0567729c2143a66d737eb0a2f63f2dce2e5a7d      PMC   \n",
       "2  ejv2xln0  06ced00a5fc04215949aa72528f2eeaae1d58927      PMC   \n",
       "3  2b73a28n  348055649b6b8cf2b9a376498df9bf41f7123605      PMC   \n",
       "4  9785vg6d  5f48792a5fa08bed9f56016f4981ae2ca6031b32      PMC   \n",
       "\n",
       "                                               title                    doi  \\\n",
       "0  Clinical features of culture-proven Mycoplasma...  10.1186/1471-2334-1-6   \n",
       "1  Nitric oxide: a pro-inflammatory mediator in l...           10.1186/rr14   \n",
       "2    Surfactant protein-D and pulmonary host defense           10.1186/rr19   \n",
       "3               Role of endothelin-1 in lung disease           10.1186/rr44   \n",
       "4  Gene expression in epithelial cells in respons...           10.1186/rr61   \n",
       "\n",
       "      pmcid   pubmed_id license  \\\n",
       "0  PMC35282  11472636.0   no-cc   \n",
       "1  PMC59543  11667967.0   no-cc   \n",
       "2  PMC59549  11667972.0   no-cc   \n",
       "3  PMC59574  11686871.0   no-cc   \n",
       "4  PMC59580  11686888.0   no-cc   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0  OBJECTIVE: This retrospective chart review des...   2001-07-04   \n",
       "1  Inflammatory diseases of the respiratory tract...   2000-08-15   \n",
       "2  Surfactant protein-D (SP-D) participates in th...   2000-08-25   \n",
       "3  Endothelin-1 (ET-1) is a 21 amino acid peptide...   2001-02-22   \n",
       "4  Respiratory syncytial virus (RSV) and pneumoni...   2001-05-11   \n",
       "\n",
       "                                             authors         journal  mag_id  \\\n",
       "0                Madani, Tariq A; Al-Ghamdi, Aisha A  BMC Infect Dis     NaN   \n",
       "1  Vliet, Albert van der; Eiserich, Jason P; Cros...      Respir Res     NaN   \n",
       "2                                    Crouch, Erika C      Respir Res     NaN   \n",
       "3  Fagan, Karen A; McMurtry, Ivan F; Rodman, David M      Respir Res     NaN   \n",
       "4  Domachowske, Joseph B; Bonville, Cynthia A; Ro...      Respir Res     NaN   \n",
       "\n",
       "  who_covidence_id arxiv_id  \\\n",
       "0              NaN      NaN   \n",
       "1              NaN      NaN   \n",
       "2              NaN      NaN   \n",
       "3              NaN      NaN   \n",
       "4              NaN      NaN   \n",
       "\n",
       "                                      pdf_json_files  \\\n",
       "0  document_parses/pdf_json/d1aafb70c066a2068b027...   \n",
       "1  document_parses/pdf_json/6b0567729c2143a66d737...   \n",
       "2  document_parses/pdf_json/06ced00a5fc04215949aa...   \n",
       "3  document_parses/pdf_json/348055649b6b8cf2b9a37...   \n",
       "4  document_parses/pdf_json/5f48792a5fa08bed9f560...   \n",
       "\n",
       "                               pmc_json_files  \\\n",
       "0  document_parses/pmc_json/PMC35282.xml.json   \n",
       "1  document_parses/pmc_json/PMC59543.xml.json   \n",
       "2  document_parses/pmc_json/PMC59549.xml.json   \n",
       "3  document_parses/pmc_json/PMC59574.xml.json   \n",
       "4  document_parses/pmc_json/PMC59580.xml.json   \n",
       "\n",
       "                                                 url  s2_id  \n",
       "0  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3...    NaN  \n",
       "1  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...    NaN  \n",
       "2  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...    NaN  \n",
       "3  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...    NaN  \n",
       "4  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...    NaN  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'OBJECTIVE: This retrospective chart review describes the epidemiology and clinical features of 40 patients with culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. METHODS: Patients with positive M. pneumoniae cultures from respiratory specimens from January 1997 through December 1998 were identified through the Microbiology records. Charts of patients were reviewed. RESULTS: 40 patients were identified, 33 (82.5%) of whom required admission. Most infections (92.5%) were community-acquired. The infection affected all age groups but was most common in infants (32.5%) and pre-school children (22.5%). It occurred year-round but was most common in the fall (35%) and spring (30%). More than three-quarters of patients (77.5%) had comorbidities. Twenty-four isolates (60%) were associated with pneumonia, 14 (35%) with upper respiratory tract infections, and 2 (5%) with bronchiolitis. Cough (82.5%), fever (75%), and malaise (58.8%) were the most common symptoms, and crepitations (60%), and wheezes (40%) were the most common signs. Most patients with pneumonia had crepitations (79.2%) but only 25% had bronchial breathing. Immunocompromised patients were more likely than non-immunocompromised patients to present with pneumonia (8/9 versus 16/31, P = 0.05). Of the 24 patients with pneumonia, 14 (58.3%) had uneventful recovery, 4 (16.7%) recovered following some complications, 3 (12.5%) died because of M pneumoniae infection, and 3 (12.5%) died due to underlying comorbidities. The 3 patients who died of M pneumoniae pneumonia had other comorbidities. CONCLUSION: our results were similar to published data except for the finding that infections were more common in infants and preschool children and that the mortality rate of pneumonia in patients with comorbidities was high.'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"abstract\"][0] #test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Inflammatory diseases of the respiratory tract are commonly associated with elevated production of nitric oxide (NO•) and increased indices of NO• -dependent oxidative stress. Although NO• is known to have anti-microbial, anti-inflammatory and anti-oxidant properties, various lines of evidence support the contribution of NO• to lung injury in several disease models. On the basis of biochemical evidence, it is often presumed that such NO• -dependent oxidations are due to the formation of the oxidant peroxynitrite, although alternative mechanisms involving the phagocyte-derived heme proteins myeloperoxidase and eosinophil peroxidase might be operative during conditions of inflammation. Because of the overwhelming literature on NO• generation and activities in the respiratory tract, it would be beyond the scope of this commentary to review this area comprehensively. Instead, it focuses on recent evidence and concepts of the presumed contribution of NO• to inflammatory diseases of the lung.'"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"abstract\"][1] #test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\ni = 0\\nfor s in df[\"abstract\"]:\\n    print(s)\\n    i+=1\\n    if(i == 5):\\n        break\\n'"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "cord_uid             object\n",
       "sha                  object\n",
       "source_x             object\n",
       "title                object\n",
       "doi                  object\n",
       "pmcid                object\n",
       "pubmed_id           float64\n",
       "license              object\n",
       "abstract             object\n",
       "publish_time         object\n",
       "authors              object\n",
       "journal              object\n",
       "mag_id              float64\n",
       "who_covidence_id     object\n",
       "arxiv_id             object\n",
       "pdf_json_files       object\n",
       "pmc_json_files       object\n",
       "url                  object\n",
       "s2_id               float64\n",
       "dtype: object"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Getting data types, might need to manipulate types later on\n",
    "df.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_dtypes = {\"title\": str, \"abstract\": str} #these dtypes must be changed in order to use sent_tokenize()\n",
    "df = df.astype(new_dtypes)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "cord_uid             object\n",
      "sha                  object\n",
      "source_x             object\n",
      "title                object\n",
      "doi                  object\n",
      "pmcid                object\n",
      "pubmed_id           float64\n",
      "license              object\n",
      "abstract             object\n",
      "publish_time         object\n",
      "authors              object\n",
      "journal              object\n",
      "mag_id              float64\n",
      "who_covidence_id     object\n",
      "arxiv_id             object\n",
      "pdf_json_files       object\n",
      "pmc_json_files       object\n",
      "url                  object\n",
      "s2_id               float64\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Time to tokenize each sentence and work in the abstract metadata\n",
    "\n",
    "sentences = []\n",
    "words = []\n",
    "\n",
    "for s in df['abstract']:\n",
    "  replace = s.replace(\"[^a-zA-Z]\", \" \")\n",
    "  clean_sentence = replace.lower()\n",
    "  sentences.append(sent_tokenize(clean_sentence))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "#puts all the sentences in a list --> no longer necessary but can be useful to maniputlate later\n",
    "sentences = [y for x in sentences for y in x] ## literally all text from all articles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Tokenizing words\n",
    "for s in df['abstract']:\n",
    "    replace = s.replace(\"[^a-zA-Z]\", \" \")\n",
    "    clean_sentence = replace.lower()\n",
    "    words.append(word_tokenize(clean_sentence))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "158947"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df['abstract'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "158947"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Stop Words:  ['m', 'such', \"doesn't\", 'mightn', ')', \"you'll\", 'yourselves', 'out', 'yours', 'until', 'same', 'over', 'him', 'other', 'been', 'down', 'couldn', 'but', 'just', 'we', 'itself', 'as', 'being', 'can', 'very', 's', 'its', 'd', \"hadn't\", 'herself', 'myself', \"don't\", 'above', 'these', 'off', 'ma', 'wouldn', 'at', 'yourself', 'below', 'each', 'or', 'of', 'ours', \"you've\", 'again', 'doesn', 'with', 'not', 'hasn', '(', \"weren't\", \"needn't\", 'that', 'after', 'there', 'any', 'did', \"hasn't\", 'into', 'too', 'o', 'about', 'during', \"mustn't\", 'both', 'are', 'few', 'be', 'more', \"wasn't\", ';', 'whom', 'do', 'his', 'having', 'those', 'further', 'why', 'will', 're', \"won't\", \"should've\", 'does', \"you're\", 'only', \"wouldn't\", \"shouldn't\", 'were', 'then', 'no', 'was', 'an', 'had', 'where', 'my', 'a', 'if', 't', 'and', 'so', 'shan', 'himself', \"you'd\", \"shan't\", 'has', \"couldn't\", 'should', 'through', 'most', ',', 'up', 've', 'this', 'wasn', ':', \"isn't\", 'from', 'didn', \"haven't\", 'their', 'needn', 'weren', 'doing', 'ain', 'our', 'hers', 'am', 'is', \"she's\", 'themselves', 'the', 'own', \"didn't\", 'me', 'them', '%', 'how', 'her', 'shouldn', 'you', 'because', 'against', \"it's\", 'once', 'for', 'to', 'than', 'what', 'under', 'have', 'when', 'y', 'don', 'by', 'your', 'it', 'he', 'they', 'she', \"aren't\", 'isn', 'haven', 'hadn', 'before', 'i', 'ourselves', 'which', 'all', \"that'll\", \"mightn't\", 'in', 'nor', 'here', '.', 'some', 'll', 'who', 'between', 'aren', 'won', 'mustn', 'now', 'while', 'theirs', 'on']\n",
      "Filtered Word Length: 15241266\n"
     ]
    }
   ],
   "source": [
    "#Filtering out stopwords\n",
    "stop_words = set(stopwords.words(\"english\"))\n",
    "newStopWords = [',','.','(',')','%',':',';']\n",
    "stop_words.update(newStopWords)\n",
    "\n",
    "non_filtered_words = []\n",
    "\n",
    "stop_words  = list(stop_words) \n",
    "print(\"Stop Words: \", stop_words)\n",
    "print()\n",
    "print()\n",
    "print()\n",
    "\n",
    "\n",
    "for w in words:\n",
    "    if w in stop_words:\n",
    "        continue\n",
    "    else:\n",
    "        non_filtered_words.append(w)\n",
    "\n",
    "filtered_words = []\n",
    "\n",
    "for part in non_filtered_words:\n",
    "    for words in part:\n",
    "        if words not in stop_words:\n",
    "            filtered_words.append(words)\n",
    "print(\"Filtered Word Length:\",len(filtered_words))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['objective', 'retrospective', 'chart', 'review', 'describes', 'epidemiology', 'clinical', 'features', '40', 'patients', 'culture-proven', 'mycoplasma', 'pneumoniae', 'infections', 'king', 'abdulaziz', 'university', 'hospital', 'jeddah', 'saudi', 'arabia', 'methods', 'patients', 'positive', 'm.', 'pneumoniae', 'cultures', 'respiratory', 'specimens', 'january', '1997', 'december', '1998', 'identified', 'microbiology', 'records', 'charts', 'patients', 'reviewed', 'results', '40', 'patients', 'identified', '33', '82.5', 'required', 'admission', 'infections', '92.5', 'community-acquired', 'infection', 'affected', 'age', 'groups', 'common', 'infants', '32.5', 'pre-school', 'children', '22.5', 'occurred', 'year-round', 'common', 'fall', '35', 'spring', '30', 'three-quarters', 'patients', '77.5', 'comorbidities', 'twenty-four', 'isolates', '60', 'associated', 'pneumonia', '14', '35', 'upper', 'respiratory', 'tract', 'infections', '2', '5', 'bronchiolitis', 'cough', '82.5', 'fever', '75', 'malaise', '58.8', 'common', 'symptoms', 'crepitations', '60', 'wheezes', '40', 'common', 'signs', 'patients', 'pneumonia', 'crepitations', '79.2', '25', 'bronchial', 'breathing', 'immunocompromised', 'patients', 'likely', 'non-immunocompromised', 'patients', 'present', 'pneumonia', '8/9', 'versus', '16/31', 'p', '=', '0.05', '24', 'patients', 'pneumonia', '14', '58.3', 'uneventful', 'recovery', '4', '16.7', 'recovered', 'following', 'complications', '3', '12.5', 'died', 'pneumoniae', 'infection', '3', '12.5', 'died', 'due', 'underlying', 'comorbidities', '3', 'patients', 'died', 'pneumoniae', 'pneumonia', 'comorbidities', 'conclusion', 'results', 'similar', 'published', 'data', 'except', 'finding', 'infections', 'common', 'infants', 'preschool', 'children', 'mortality', 'rate', 'pneumonia', 'patients', 'comorbidities', 'high', 'inflammatory', 'diseases', 'respiratory', 'tract', 'commonly', 'associated', 'elevated', 'production', 'nitric', 'oxide', 'no•', 'increased', 'indices', 'no•', '-dependent', 'oxidative', 'stress', 'although', 'no•', 'known', 'anti-microbial', 'anti-inflammatory', 'anti-oxidant', 'properties', 'various', 'lines', 'evidence', 'support', 'contribution', 'no•', 'lung', 'injury', 'several', 'disease', 'models', 'basis', 'biochemical', 'evidence', 'often', 'presumed', 'no•', '-dependent', 'oxidations', 'due', 'formation', 'oxidant', 'peroxynitrite', 'although', 'alternative', 'mechanisms', 'involving', 'phagocyte-derived', 'heme', 'proteins', 'myeloperoxidase', 'eosinophil', 'peroxidase', 'might', 'operative', 'conditions', 'inflammation', 'overwhelming', 'literature', 'no•', 'generation', 'activities', 'respiratory', 'tract', 'would', 'beyond', 'scope', 'commentary', 'review', 'area', 'comprehensively', 'instead', 'focuses', 'recent', 'evidence', 'concepts', 'presumed', 'contribution', 'no•', 'inflammatory', 'diseases', 'lung', 'surfactant', 'protein-d', 'sp-d', 'participates', 'innate', 'response', 'inhaled', 'microorganisms', 'organic', 'antigens', 'contributes', 'immune', 'inflammatory', 'regulation', 'within', 'lung', 'sp-d', 'synthesized', 'secreted', 'alveolar', 'bronchiolar', 'epithelial', 'cells', 'also', 'expressed', 'epithelial', 'cells', 'lining', 'various', 'exocrine', 'ducts', 'mucosa', 'gastrointestinal', 'genitourinary', 'tracts', 'sp-d', 'collagenous', 'calcium-dependent', 'lectin', 'collectin', 'binds', 'surface', 'glycoconjugates', 'expressed', 'wide', 'variety', 'microorganisms', 'oligosaccharides', 'associated', 'surface', 'various', 'complex', 'organic', 'antigens', 'sp-d', 'also', 'specifically', 'interacts', 'glycoconjugates', 'molecules', 'expressed', 'surface', 'macrophages', 'neutrophils', 'lymphocytes', 'addition', 'sp-d', 'binds', 'specific', 'surfactant-associated', 'lipids', 'influence', 'organization', 'lipid', 'mixtures', 'containing', 'phosphatidylinositol', 'vitro', 'consistent', 'diverse', 'vitro', 'activities', 'observation', 'sp-d-deficient', 'transgenic', 'mice', 'show', 'abnormal', 'accumulations', 'surfactant', 'lipids', 'respond', 'abnormally', 'challenge', 'respiratory', 'viruses', 'bacterial', 'lipopolysaccharides', 'phenotype', 'macrophages', 'isolated', 'lungs', 'sp-d-deficient', 'mice', 'altered', 'circumstantial', 'evidence', 'abnormal', 'oxidant', 'metabolism', 'and/or', 'increased', 'metalloproteinase', 'expression', 'contributes', 'development', 'emphysema', 'expression', 'sp-d', 'increased', 'response', 'many', 'forms', 'lung', 'injury', 'deficient', 'accumulation', 'appropriately', 'oligomerized', 'sp-d', 'might', 'contribute', 'pathogenesis', 'variety', 'human', 'lung', 'diseases', 'endothelin-1', 'et-1', '21', 'amino', 'acid', 'peptide', 'diverse', 'biological', 'activity', 'implicated', 'numerous', 'diseases', 'et-1', 'potent', 'mitogen', 'regulator', 'smooth', 'muscle', 'tone', 'inflammatory', 'mediator', 'may', 'play', 'key', 'role', 'diseases', 'airways', 'pulmonary', 'circulation', 'inflammatory', 'lung', 'diseases', 'acute', 'chronic', 'review', 'focus', 'biology', 'et-1', 'role', 'lung', 'disease', 'respiratory', 'syncytial', 'virus', 'rsv', 'pneumonia', 'virus', 'mice', 'pvm', 'viruses', 'family', 'paramyxoviridae', 'subfamily', 'pneumovirus', 'cause', 'clinically', 'important', 'respiratory', 'infections', 'humans', 'rodents', 'respectively', 'respiratory', 'epithelial', 'target', 'cells', 'respond', 'viral', 'infection', 'specific', 'alterations', 'gene', 'expression', 'including', 'production', 'chemoattractant', 'cytokines', 'adhesion', 'molecules', 'elements', 'related', 'apoptosis', 'response', 'others', 'remain', 'incompletely', 'understood', 'review', 'current', 'understanding', 'mucosal', 'responses', 'discuss', 'several', 'genomic', 'approaches', 'including', 'differential', 'display', 'reverse', 'transcription-polymerase', 'chain', 'reaction', 'pcr', 'gene', 'array', 'strategies', 'permit', 'us', 'unravel', 'nature', 'responses', 'complete', 'systematic', 'manner', 'nidovirus', 'subgenomic', 'mrnas', 'contain', 'leader', 'sequence', 'derived', '5′', 'end', 'genome', 'fused', 'different', 'sequences', '‘', 'bodies', '’', 'derived', '3′', 'end', 'generation', 'involves', 'unique', 'mechanism', 'discontinuous', 'subgenomic', 'rna', 'synthesis', 'resembles', 'copy-choice', 'rna', 'recombination', 'process', 'nascent', 'rna', 'strand', 'transferred', 'one', 'site', 'template', 'another', 'either', 'plus', 'minus', 'strand', 'synthesis', 'yield', 'subgenomic', 'rna', 'molecules', 'central', 'process', 'transcription-regulating', 'sequences', 'trss', 'present', 'template', 'sites', 'ensure', 'fidelity', 'strand', 'transfer', 'present', 'results', 'comprehensive', 'co-variation', 'mutagenesis', 'study', 'equine', 'arteritis', 'virus', 'trss', 'demonstrating', 'discontinuous', 'rna', 'synthesis', 'depends', 'base', 'pairing', 'sense', 'leader', 'trs', 'antisense', 'body', 'trs', 'also', 'primary', 'sequence', 'body', 'trs', 'leader', 'trs', 'merely', 'plays', 'targeting', 'role', 'strand', 'transfer', 'body', 'trs', 'fulfils', 'multiple', 'functions', 'sequences', 'mrna', 'leader–body', 'junctions', 'trs', 'mutants', 'strongly', 'suggested', 'discontinuous', 'step', 'occurs', 'minus', 'strand', 'synthesis', 'recent', 'evidence', 'suggests', 'critically', 'ill', 'patients', 'able', 'tolerate', 'lower', 'levels', 'haemoglobin', 'previously', 'believed', 'goal', 'show', 'transfusing', 'level', '100', 'g/l', 'improve', 'mortality', 'clinically', 'important', 'outcomes', 'critical', 'care', 'setting', 'although', 'many', 'questions', 'remain', 'many', 'laboratory', 'clinical', 'studies', 'including', 'recent', 'randomized', 'controlled', 'trial', 'rct', 'established', 'transfusing', 'normal', 'haemoglobin', 'concentrations', 'improve', 'organ', 'failure', 'mortality', 'critically', 'ill', 'patient', 'addition', 'restrictive', 'transfusion', 'strategy', 'reduce', 'exposure', 'allogeneic', 'transfusions', 'result', 'efficient', 'use', 'red', 'blood', 'cells', 'rbcs', 'save', 'blood', 'overall', 'decrease', 'health', 'care', 'costs', '21st', 'international', 'symposium', 'intensive', 'care', 'emergency', 'medicine', 'dominated', 'results', 'recent', 'clinical', 'trials', 'sepsis', 'acute', 'respiratory', 'distress', 'syndrome', 'ards', 'promise', 'extracorporeal', 'liver', 'replacement', 'therapy', 'noninvasive', 'ventilation', 'areas', 'interest', 'ethical', 'issues', 'also', 'received', 'attention', 'overall', \"'state\", 'art', \"'\", 'lectures', 'pro/con', 'debates', 'seminars', 'tutorials', 'high', 'standard', 'meeting', 'marked', 'sense', 'renewed', 'enthusiasm', 'positive', 'progress', 'occurring', 'intensive', 'care', 'medicine', 'heme', 'oxygenase-1', 'ho-1', 'inducible', 'stress', 'protein', 'confers', 'cytoprotection', 'oxidative', 'stress', 'vitro', 'vivo', 'addition', 'physiological', 'role', 'heme', 'degradation', 'ho-1', 'may', 'influence', 'number', 'cellular', 'processes', 'including', 'growth', 'inflammation', 'apoptosis', 'virtue', 'anti-inflammatory', 'effects', 'ho-1', 'limits', 'tissue', 'damage', 'response', 'proinflammatory', 'stimuli', 'prevents', 'allograft', 'rejection', 'transplantation', 'transcriptional', 'upregulation', 'ho-1', 'responds', 'many', 'agents', 'hypoxia', 'bacterial', 'lipopolysaccharide', 'reactive', 'oxygen/nitrogen', 'species', 'ho-1', 'constitutively', 'expressed', 'isozyme', 'heme', 'oxygenase-2', 'catalyze', 'rate-limiting', 'step', 'conversion', 'heme', 'metabolites', 'bilirubin', 'ixα', 'ferrous', 'iron', 'carbon', 'monoxide', 'co', 'mechanisms', 'ho-1', 'provides', 'protection', 'likely', 'involve', 'enzymatic', 'reaction', 'products', 'remarkably', 'administration', 'co', 'low', 'concentrations', 'substitute', 'ho-1', 'respect', 'anti-inflammatory', 'anti-apoptotic', 'effects', 'suggesting', 'role', 'co', 'key', 'mediator', 'ho-1', 'function', 'chronic', 'low-level', 'exogenous', 'exposure', 'co', 'cigarette', 'smoking', 'contributes', 'importance', 'co', 'pulmonary', 'medicine', 'implications', 'ho-1/co', 'system', 'pulmonary', 'diseases', 'discussed', 'review', 'emphasis', 'inflammatory', 'states', 'report', 'describes', 'design', 'implementation', 'real-time', 'outbreak', 'disease', 'surveillance', 'rods', 'system', 'computer-based', 'public', 'health', 'surveillance', 'system', 'early', 'detection', 'disease', 'outbreaks', 'hospitals', 'send', 'rods', 'data', 'clinical', 'encounters', 'virtual', 'private', 'networks', 'leased', 'lines', 'using', 'health', 'level', '7', 'hl7', 'message', 'protocol', 'data', 'sent', 'real', 'time', 'rods', 'automatically', 'classifies', 'registration', 'chief', 'complaint', 'visit', 'one', 'seven', 'syndrome', 'categories', 'using', 'bayesian', 'classifiers', 'stores', 'data', 'relational', 'database', 'aggregates', 'data', 'analysis', 'using', 'data', 'warehousing', 'techniques', 'applies', 'univariate', 'multivariate', 'statistical', 'detection', 'algorithms', 'data', 'alerts', 'users', 'algorithms', 'identify', 'anomalous', 'patterns', 'syndrome', 'counts', 'rods', 'also', 'web-based', 'user', 'interface', 'supports', 'temporal', 'spatial', 'analyses', 'rods', 'processes', 'sales', 'over-the-counter', 'health', 'care', 'products', 'similar', 'manner', 'receives', 'data', 'batch', 'mode', 'daily', 'basis', 'rods', 'used', '2002', 'winter', 'olympics', 'currently', 'operates', 'two', 'states—pennsylvania', 'utah', 'continues', 'resource', 'implementing', 'evaluating', 'applying', 'new', 'methods', 'public', 'health', 'surveillance', 'regulation', 'ornithine', 'decarboxylase', 'vertebrates', 'involves']\n"
     ]
    }
   ],
   "source": [
    "print(filtered_words[:500]) # first 500 words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Not currently used; \n",
    "    # portstemmer allows me to take just the stem of each word for the word freq.\n",
    "    # may use later, could be useful for phrases too\n",
    "\n",
    "ps = PorterStemmer()\n",
    "stemmed_words = []\n",
    "\n",
    "#for words in filtered_words:\n",
    "#    sample_w = ps.stem(words)\n",
    "#    stemmed_words.append(sample_w)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_frequency_table(list1) -> dict:\n",
    "\n",
    "    freqTable = dict()\n",
    "    for word in list1:\n",
    "        if word in freqTable:\n",
    "            freqTable[word] += 1\n",
    "        else:\n",
    "            freqTable[word] = 1\n",
    "\n",
    "    return freqTable"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "freqTable = create_frequency_table(filtered_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'objective': 10298,\n",
       " 'retrospective': 4490,\n",
       " 'chart': 386,\n",
       " 'review': 19579,\n",
       " 'describes': 2034,\n",
       " 'epidemiology': 3061,\n",
       " 'clinical': 44703,\n",
       " 'features': 6415,\n",
       " '40': 3480,\n",
       " 'patients': 131641,\n",
       " 'culture-proven': 8,\n",
       " 'mycoplasma': 856,\n",
       " 'pneumoniae': 1884,\n",
       " 'infections': 22698,\n",
       " 'king': 186,\n",
       " 'abdulaziz': 22,\n",
       " 'university': 2990,\n",
       " 'hospital': 16439,\n",
       " 'jeddah': 91,\n",
       " 'saudi': 1143,\n",
       " 'arabia': 930,\n",
       " 'methods': 36538,\n",
       " 'positive': 15850,\n",
       " 'm.': 1779,\n",
       " 'cultures': 1994,\n",
       " 'respiratory': 48768,\n",
       " 'specimens': 4714,\n",
       " 'january': 5709,\n",
       " '1997': 268,\n",
       " 'december': 4816,\n",
       " '1998': 274,\n",
       " 'identified': 18131,\n",
       " 'microbiology': 560,\n",
       " 'records': 2025,\n",
       " 'charts': 210,\n",
       " 'reviewed': 4129,\n",
       " 'results': 58843,\n",
       " '33': 1791,\n",
       " '82.5': 47,\n",
       " 'required': 8377,\n",
       " 'admission': 5051,\n",
       " '92.5': 53,\n",
       " 'community-acquired': 899,\n",
       " 'infection': 56463,\n",
       " 'affected': 5884,\n",
       " 'age': 16769,\n",
       " 'groups': 15243,\n",
       " 'common': 13873,\n",
       " 'infants': 3978,\n",
       " '32.5': 83,\n",
       " 'pre-school': 25,\n",
       " 'children': 16223,\n",
       " '22.5': 94,\n",
       " 'occurred': 6220,\n",
       " 'year-round': 29,\n",
       " 'fall': 522,\n",
       " '35': 2184,\n",
       " 'spring': 480,\n",
       " '30': 6593,\n",
       " 'three-quarters': 40,\n",
       " '77.5': 45,\n",
       " 'comorbidities': 2543,\n",
       " 'twenty-four': 207,\n",
       " 'isolates': 3709,\n",
       " '60': 3550,\n",
       " 'associated': 27308,\n",
       " 'pneumonia': 12322,\n",
       " '14': 5548,\n",
       " 'upper': 3470,\n",
       " 'tract': 6437,\n",
       " '2': 32768,\n",
       " '5': 12842,\n",
       " 'bronchiolitis': 1307,\n",
       " 'cough': 3171,\n",
       " 'fever': 6733,\n",
       " '75': 1724,\n",
       " 'malaise': 160,\n",
       " '58.8': 49,\n",
       " 'symptoms': 15059,\n",
       " 'crepitations': 6,\n",
       " 'wheezes': 8,\n",
       " 'signs': 3856,\n",
       " '79.2': 59,\n",
       " '25': 4213,\n",
       " 'bronchial': 783,\n",
       " 'breathing': 1143,\n",
       " 'immunocompromised': 1003,\n",
       " 'likely': 7600,\n",
       " 'non-immunocompromised': 31,\n",
       " 'present': 15540,\n",
       " '8/9': 23,\n",
       " 'versus': 5070,\n",
       " '16/31': 3,\n",
       " 'p': 36225,\n",
       " '=': 36609,\n",
       " '0.05': 4434,\n",
       " '24': 5419,\n",
       " '58.3': 84,\n",
       " 'uneventful': 219,\n",
       " 'recovery': 3868,\n",
       " '4': 12301,\n",
       " '16.7': 242,\n",
       " 'recovered': 2178,\n",
       " 'following': 9335,\n",
       " 'complications': 11974,\n",
       " '3': 20292,\n",
       " '12.5': 339,\n",
       " 'died': 2967,\n",
       " 'due': 13251,\n",
       " 'underlying': 3978,\n",
       " 'conclusion': 14621,\n",
       " 'similar': 10100,\n",
       " 'published': 5196,\n",
       " 'data': 39301,\n",
       " 'except': 1665,\n",
       " 'finding': 1863,\n",
       " 'preschool': 97,\n",
       " 'mortality': 17012,\n",
       " 'rate': 19181,\n",
       " 'high': 22345,\n",
       " 'inflammatory': 5777,\n",
       " 'diseases': 18830,\n",
       " 'commonly': 3468,\n",
       " 'elevated': 2819,\n",
       " 'production': 6552,\n",
       " 'nitric': 456,\n",
       " 'oxide': 673,\n",
       " 'no•': 7,\n",
       " 'increased': 17913,\n",
       " 'indices': 631,\n",
       " '-dependent': 102,\n",
       " 'oxidative': 766,\n",
       " 'stress': 4291,\n",
       " 'although': 11048,\n",
       " 'known': 8955,\n",
       " 'anti-microbial': 47,\n",
       " 'anti-inflammatory': 1256,\n",
       " 'anti-oxidant': 30,\n",
       " 'properties': 4125,\n",
       " 'various': 8790,\n",
       " 'lines': 2149,\n",
       " 'evidence': 14809,\n",
       " 'support': 9001,\n",
       " 'contribution': 1291,\n",
       " 'lung': 13454,\n",
       " 'injury': 6206,\n",
       " 'several': 11837,\n",
       " 'disease': 59064,\n",
       " 'models': 9893,\n",
       " 'basis': 3324,\n",
       " 'biochemical': 1274,\n",
       " 'often': 6032,\n",
       " 'presumed': 347,\n",
       " 'oxidations': 3,\n",
       " 'formation': 3603,\n",
       " 'oxidant': 41,\n",
       " 'peroxynitrite': 27,\n",
       " 'alternative': 3861,\n",
       " 'mechanisms': 7381,\n",
       " 'involving': 2175,\n",
       " 'phagocyte-derived': 1,\n",
       " 'heme': 63,\n",
       " 'proteins': 14637,\n",
       " 'myeloperoxidase': 64,\n",
       " 'eosinophil': 245,\n",
       " 'peroxidase': 79,\n",
       " 'might': 6554,\n",
       " 'operative': 3298,\n",
       " 'conditions': 8086,\n",
       " 'inflammation': 4395,\n",
       " 'overwhelming': 344,\n",
       " 'literature': 7363,\n",
       " 'generation': 2201,\n",
       " 'activities': 4714,\n",
       " 'would': 6573,\n",
       " 'beyond': 1460,\n",
       " 'scope': 653,\n",
       " 'commentary': 533,\n",
       " 'area': 4851,\n",
       " 'comprehensively': 347,\n",
       " 'instead': 922,\n",
       " 'focuses': 1091,\n",
       " 'recent': 10350,\n",
       " 'concepts': 826,\n",
       " 'surfactant': 367,\n",
       " 'protein-d': 4,\n",
       " 'sp-d': 117,\n",
       " 'participates': 97,\n",
       " 'innate': 3413,\n",
       " 'response': 18433,\n",
       " 'inhaled': 482,\n",
       " 'microorganisms': 1020,\n",
       " 'organic': 563,\n",
       " 'antigens': 2290,\n",
       " 'contributes': 837,\n",
       " 'immune': 14035,\n",
       " 'regulation': 2179,\n",
       " 'within': 14520,\n",
       " 'synthesized': 1187,\n",
       " 'secreted': 540,\n",
       " 'alveolar': 1653,\n",
       " 'bronchiolar': 91,\n",
       " 'epithelial': 2953,\n",
       " 'cells': 34528,\n",
       " 'also': 33537,\n",
       " 'expressed': 4297,\n",
       " 'lining': 127,\n",
       " 'exocrine': 51,\n",
       " 'ducts': 67,\n",
       " 'mucosa': 807,\n",
       " 'gastrointestinal': 2604,\n",
       " 'genitourinary': 61,\n",
       " 'tracts': 234,\n",
       " 'collagenous': 11,\n",
       " 'calcium-dependent': 28,\n",
       " 'lectin': 510,\n",
       " 'collectin': 15,\n",
       " 'binds': 730,\n",
       " 'surface': 5222,\n",
       " 'glycoconjugates': 46,\n",
       " 'wide': 2688,\n",
       " 'variety': 2999,\n",
       " 'oligosaccharides': 179,\n",
       " 'complex': 6838,\n",
       " 'specifically': 2944,\n",
       " 'interacts': 389,\n",
       " 'molecules': 3123,\n",
       " 'macrophages': 2386,\n",
       " 'neutrophils': 873,\n",
       " 'lymphocytes': 1654,\n",
       " 'addition': 8935,\n",
       " 'specific': 13399,\n",
       " 'surfactant-associated': 3,\n",
       " 'lipids': 344,\n",
       " 'influence': 3559,\n",
       " 'organization': 3600,\n",
       " 'lipid': 1417,\n",
       " 'mixtures': 181,\n",
       " 'containing': 3019,\n",
       " 'phosphatidylinositol': 87,\n",
       " 'vitro': 6044,\n",
       " 'consistent': 2850,\n",
       " 'diverse': 2486,\n",
       " 'observation': 1306,\n",
       " 'sp-d-deficient': 2,\n",
       " 'transgenic': 721,\n",
       " 'mice': 9860,\n",
       " 'show': 8671,\n",
       " 'abnormal': 1400,\n",
       " 'accumulations': 23,\n",
       " 'respond': 1230,\n",
       " 'abnormally': 69,\n",
       " 'challenge': 4924,\n",
       " 'viruses': 28845,\n",
       " 'bacterial': 5899,\n",
       " 'lipopolysaccharides': 23,\n",
       " 'phenotype': 1010,\n",
       " 'isolated': 4911,\n",
       " 'lungs': 2243,\n",
       " 'altered': 1370,\n",
       " 'circumstantial': 20,\n",
       " 'metabolism': 1155,\n",
       " 'and/or': 4747,\n",
       " 'metalloproteinase': 56,\n",
       " 'expression': 14256,\n",
       " 'development': 15871,\n",
       " 'emphysema': 222,\n",
       " 'many': 13653,\n",
       " 'forms': 2034,\n",
       " 'deficient': 383,\n",
       " 'accumulation': 1287,\n",
       " 'appropriately': 433,\n",
       " 'oligomerized': 3,\n",
       " 'contribute': 3217,\n",
       " 'pathogenesis': 4745,\n",
       " 'human': 27354,\n",
       " 'endothelin-1': 17,\n",
       " 'et-1': 32,\n",
       " '21': 3497,\n",
       " 'amino': 4148,\n",
       " 'acid': 8102,\n",
       " 'peptide': 3035,\n",
       " 'biological': 4780,\n",
       " 'activity': 14205,\n",
       " 'implicated': 1072,\n",
       " 'numerous': 2074,\n",
       " 'potent': 2002,\n",
       " 'mitogen': 48,\n",
       " 'regulator': 404,\n",
       " 'smooth': 354,\n",
       " 'muscle': 2130,\n",
       " 'tone': 107,\n",
       " 'mediator': 226,\n",
       " 'may': 38053,\n",
       " 'play': 3931,\n",
       " 'key': 7370,\n",
       " 'role': 15434,\n",
       " 'airways': 733,\n",
       " 'pulmonary': 7203,\n",
       " 'circulation': 1615,\n",
       " 'acute': 28170,\n",
       " 'chronic': 7547,\n",
       " 'focus': 3979,\n",
       " 'biology': 1930,\n",
       " 'syncytial': 2486,\n",
       " 'virus': 62451,\n",
       " 'rsv': 4230,\n",
       " 'pvm': 60,\n",
       " 'family': 5306,\n",
       " 'paramyxoviridae': 138,\n",
       " 'subfamily': 147,\n",
       " 'pneumovirus': 44,\n",
       " 'cause': 9253,\n",
       " 'clinically': 2952,\n",
       " 'important': 17016,\n",
       " 'humans': 6216,\n",
       " 'rodents': 454,\n",
       " 'respectively': 14592,\n",
       " 'target': 6991,\n",
       " 'viral': 40505,\n",
       " 'alterations': 1023,\n",
       " 'gene': 12557,\n",
       " 'including': 22356,\n",
       " 'chemoattractant': 93,\n",
       " 'cytokines': 2777,\n",
       " 'adhesion': 1022,\n",
       " 'elements': 1609,\n",
       " 'related': 11645,\n",
       " 'apoptosis': 2082,\n",
       " 'others': 2471,\n",
       " 'remain': 3291,\n",
       " 'incompletely': 219,\n",
       " 'understood': 1746,\n",
       " 'current': 13779,\n",
       " 'understanding': 8076,\n",
       " 'mucosal': 1832,\n",
       " 'responses': 9512,\n",
       " 'discuss': 4131,\n",
       " 'genomic': 2927,\n",
       " 'approaches': 5509,\n",
       " 'differential': 1856,\n",
       " 'display': 939,\n",
       " 'reverse': 3275,\n",
       " 'transcription-polymerase': 296,\n",
       " 'chain': 4828,\n",
       " 'reaction': 5321,\n",
       " 'pcr': 7073,\n",
       " 'array': 804,\n",
       " 'strategies': 9741,\n",
       " 'permit': 255,\n",
       " 'us': 5053,\n",
       " 'unravel': 105,\n",
       " 'nature': 2576,\n",
       " 'complete': 5045,\n",
       " 'systematic': 5193,\n",
       " 'manner': 1824,\n",
       " 'nidovirus': 143,\n",
       " 'subgenomic': 800,\n",
       " 'mrnas': 1026,\n",
       " 'contain': 2171,\n",
       " 'leader': 595,\n",
       " 'sequence': 7917,\n",
       " 'derived': 2886,\n",
       " '5′': 442,\n",
       " 'end': 4377,\n",
       " 'genome': 7180,\n",
       " 'fused': 441,\n",
       " 'different': 22580,\n",
       " 'sequences': 6093,\n",
       " '‘': 2360,\n",
       " 'bodies': 695,\n",
       " '’': 12456,\n",
       " '3′': 458,\n",
       " 'involves': 1118,\n",
       " 'unique': 4011,\n",
       " 'mechanism': 5294,\n",
       " 'discontinuous': 187,\n",
       " 'rna': 17719,\n",
       " 'synthesis': 3712,\n",
       " 'resembles': 159,\n",
       " 'copy-choice': 14,\n",
       " 'recombination': 1792,\n",
       " 'process': 7042,\n",
       " 'nascent': 146,\n",
       " 'strand': 376,\n",
       " 'transferred': 653,\n",
       " 'one': 25772,\n",
       " 'site': 5248,\n",
       " 'template': 603,\n",
       " 'another': 2512,\n",
       " 'either': 6471,\n",
       " 'plus': 1685,\n",
       " 'minus': 90,\n",
       " 'yield': 1259,\n",
       " 'central': 4746,\n",
       " 'transcription-regulating': 29,\n",
       " 'trss': 41,\n",
       " 'sites': 4213,\n",
       " 'ensure': 2073,\n",
       " 'fidelity': 304,\n",
       " 'transfer': 1973,\n",
       " 'comprehensive': 2850,\n",
       " 'co-variation': 5,\n",
       " 'mutagenesis': 506,\n",
       " 'study': 56647,\n",
       " 'equine': 734,\n",
       " 'arteritis': 199,\n",
       " 'demonstrating': 866,\n",
       " 'depends': 1038,\n",
       " 'base': 1543,\n",
       " 'pairing': 113,\n",
       " 'sense': 693,\n",
       " 'trs': 117,\n",
       " 'antisense': 271,\n",
       " 'body': 5474,\n",
       " 'primary': 10941,\n",
       " 'merely': 114,\n",
       " 'plays': 2107,\n",
       " 'targeting': 3186,\n",
       " 'fulfils': 13,\n",
       " 'multiple': 9276,\n",
       " 'functions': 3632,\n",
       " 'mrna': 3049,\n",
       " 'leader–body': 2,\n",
       " 'junctions': 149,\n",
       " 'mutants': 1131,\n",
       " 'strongly': 2202,\n",
       " 'suggested': 3611,\n",
       " 'step': 1909,\n",
       " 'occurs': 1908,\n",
       " 'suggests': 4058,\n",
       " 'critically': 2723,\n",
       " 'ill': 2769,\n",
       " 'able': 3639,\n",
       " 'tolerate': 104,\n",
       " 'lower': 12483,\n",
       " 'levels': 14534,\n",
       " 'haemoglobin': 108,\n",
       " 'previously': 5864,\n",
       " 'believed': 744,\n",
       " 'goal': 1689,\n",
       " 'transfusing': 7,\n",
       " 'level': 11177,\n",
       " '100': 5844,\n",
       " 'g/l': 171,\n",
       " 'improve': 6193,\n",
       " 'outcomes': 15499,\n",
       " 'critical': 9001,\n",
       " 'care': 26832,\n",
       " 'setting': 4790,\n",
       " 'questions': 2418,\n",
       " 'laboratory': 6983,\n",
       " 'studies': 29168,\n",
       " 'randomized': 4473,\n",
       " 'controlled': 4185,\n",
       " 'trial': 5985,\n",
       " 'rct': 361,\n",
       " 'established': 4502,\n",
       " 'normal': 5134,\n",
       " 'concentrations': 3601,\n",
       " 'organ': 2611,\n",
       " 'failure': 6349,\n",
       " 'patient': 21411,\n",
       " 'restrictive': 378,\n",
       " 'transfusion': 1241,\n",
       " 'strategy': 5564,\n",
       " 'reduce': 6752,\n",
       " 'exposure': 6741,\n",
       " 'allogeneic': 408,\n",
       " 'transfusions': 242,\n",
       " 'result': 6644,\n",
       " 'efficient': 3386,\n",
       " 'use': 24956,\n",
       " 'red': 880,\n",
       " 'blood': 13135,\n",
       " 'rbcs': 97,\n",
       " 'save': 322,\n",
       " 'overall': 8337,\n",
       " 'decrease': 4098,\n",
       " 'health': 46065,\n",
       " 'costs': 2192,\n",
       " '21st': 303,\n",
       " 'international': 5805,\n",
       " 'symposium': 86,\n",
       " 'intensive': 5477,\n",
       " 'emergency': 7524,\n",
       " 'medicine': 4528,\n",
       " 'dominated': 315,\n",
       " 'trials': 7705,\n",
       " 'sepsis': 1872,\n",
       " 'distress': 3472,\n",
       " 'syndrome': 18719,\n",
       " 'ards': 3130,\n",
       " 'promise': 657,\n",
       " 'extracorporeal': 822,\n",
       " 'liver': 6722,\n",
       " 'replacement': 1071,\n",
       " 'therapy': 12080,\n",
       " 'noninvasive': 723,\n",
       " 'ventilation': 6024,\n",
       " 'areas': 5466,\n",
       " 'interest': 2889,\n",
       " 'ethical': 1345,\n",
       " 'issues': 3265,\n",
       " 'received': 4911,\n",
       " 'attention': 3397,\n",
       " \"'state\": 2,\n",
       " 'art': 433,\n",
       " \"'\": 8211,\n",
       " 'lectures': 96,\n",
       " 'pro/con': 1,\n",
       " 'debates': 104,\n",
       " 'seminars': 35,\n",
       " 'tutorials': 22,\n",
       " 'standard': 7038,\n",
       " 'meeting': 872,\n",
       " 'marked': 1085,\n",
       " 'renewed': 168,\n",
       " 'enthusiasm': 50,\n",
       " 'progress': 2163,\n",
       " 'occurring': 1477,\n",
       " 'oxygenase-1': 14,\n",
       " 'ho-1': 49,\n",
       " 'inducible': 233,\n",
       " 'protein': 26961,\n",
       " 'confers': 179,\n",
       " 'cytoprotection': 2,\n",
       " 'vivo': 4769,\n",
       " 'physiological': 1521,\n",
       " 'degradation': 1385,\n",
       " 'number': 20973,\n",
       " 'cellular': 6553,\n",
       " 'processes': 3774,\n",
       " 'growth': 5655,\n",
       " 'virtue': 86,\n",
       " 'effects': 13342,\n",
       " 'limits': 898,\n",
       " 'tissue': 7668,\n",
       " 'damage': 3174,\n",
       " 'proinflammatory': 696,\n",
       " 'stimuli': 387,\n",
       " 'prevents': 363,\n",
       " 'allograft': 301,\n",
       " 'rejection': 392,\n",
       " 'transplantation': 2091,\n",
       " 'transcriptional': 787,\n",
       " 'upregulation': 490,\n",
       " 'responds': 104,\n",
       " 'agents': 7054,\n",
       " 'hypoxia': 589,\n",
       " 'lipopolysaccharide': 299,\n",
       " 'reactive': 846,\n",
       " 'oxygen/nitrogen': 1,\n",
       " 'species': 9164,\n",
       " 'constitutively': 135,\n",
       " 'isozyme': 8,\n",
       " 'oxygenase-2': 1,\n",
       " 'catalyze': 84,\n",
       " 'rate-limiting': 38,\n",
       " 'conversion': 1653,\n",
       " 'metabolites': 521,\n",
       " 'bilirubin': 251,\n",
       " 'ixα': 1,\n",
       " 'ferrous': 15,\n",
       " 'iron': 462,\n",
       " 'carbon': 746,\n",
       " 'monoxide': 69,\n",
       " 'co': 875,\n",
       " 'provides': 5968,\n",
       " 'protection': 5095,\n",
       " 'involve': 845,\n",
       " 'enzymatic': 560,\n",
       " 'products': 3126,\n",
       " 'remarkably': 538,\n",
       " 'administration': 3820,\n",
       " 'low': 10581,\n",
       " 'substitute': 172,\n",
       " 'respect': 1614,\n",
       " 'anti-apoptotic': 61,\n",
       " 'suggesting': 3862,\n",
       " 'function': 9247,\n",
       " 'low-level': 105,\n",
       " 'exogenous': 489,\n",
       " 'cigarette': 154,\n",
       " 'smoking': 1196,\n",
       " 'importance': 5684,\n",
       " 'implications': 3102,\n",
       " 'ho-1/co': 1,\n",
       " 'system': 19347,\n",
       " 'discussed': 3731,\n",
       " 'emphasis': 1010,\n",
       " 'states': 5700,\n",
       " 'report': 9718,\n",
       " 'design': 8209,\n",
       " 'implementation': 3356,\n",
       " 'real-time': 4279,\n",
       " 'outbreak': 15483,\n",
       " 'surveillance': 6664,\n",
       " 'rods': 29,\n",
       " 'computer-based': 38,\n",
       " 'public': 16556,\n",
       " 'early': 14099,\n",
       " 'detection': 13039,\n",
       " 'outbreaks': 6274,\n",
       " 'hospitals': 5161,\n",
       " 'send': 49,\n",
       " 'encounters': 257,\n",
       " 'virtual': 1307,\n",
       " 'private': 791,\n",
       " 'networks': 2289,\n",
       " 'leased': 1,\n",
       " 'using': 38585,\n",
       " '7': 7198,\n",
       " 'hl7': 3,\n",
       " 'message': 252,\n",
       " 'protocol': 2981,\n",
       " 'sent': 501,\n",
       " 'real': 1885,\n",
       " 'time': 26602,\n",
       " 'automatically': 329,\n",
       " 'classifies': 33,\n",
       " 'registration': 1832,\n",
       " 'chief': 205,\n",
       " 'complaint': 94,\n",
       " 'visit': 798,\n",
       " 'seven': 3278,\n",
       " 'categories': 1109,\n",
       " 'bayesian': 599,\n",
       " 'classifiers': 116,\n",
       " 'stores': 101,\n",
       " 'relational': 105,\n",
       " 'database': 3185,\n",
       " 'aggregates': 189,\n",
       " 'analysis': 26537,\n",
       " 'warehousing': 3,\n",
       " 'techniques': 5899,\n",
       " 'applies': 165,\n",
       " 'univariate': 697,\n",
       " 'multivariate': 1976,\n",
       " 'statistical': 2622,\n",
       " 'algorithms': 1087,\n",
       " 'alerts': 155,\n",
       " 'users': 2749,\n",
       " 'identify': 9222,\n",
       " 'anomalous': 84,\n",
       " 'patterns': 4009,\n",
       " 'counts': 1589,\n",
       " 'web-based': 406,\n",
       " 'user': 751,\n",
       " 'interface': 1064,\n",
       " 'supports': 1011,\n",
       " 'temporal': 1277,\n",
       " 'spatial': 1748,\n",
       " 'analyses': 5326,\n",
       " 'sales': 150,\n",
       " 'over-the-counter': 47,\n",
       " 'receives': 57,\n",
       " 'batch': 107,\n",
       " 'mode': 1414,\n",
       " 'daily': 4729,\n",
       " 'used': 32225,\n",
       " '2002': 775,\n",
       " 'winter': 963,\n",
       " 'olympics': 19,\n",
       " 'currently': 6486,\n",
       " 'operates': 98,\n",
       " 'two': 28773,\n",
       " 'states—pennsylvania': 1,\n",
       " 'utah': 62,\n",
       " 'continues': 1252,\n",
       " 'resource': 1705,\n",
       " 'implementing': 821,\n",
       " 'evaluating': 1478,\n",
       " 'applying': 813,\n",
       " 'new': 23738,\n",
       " 'ornithine': 12,\n",
       " 'decarboxylase': 25,\n",
       " 'vertebrates': 186,\n",
       " 'negative': 7728,\n",
       " 'feedback': 628,\n",
       " 'requiring': 2594,\n",
       " 'antizyme': 12,\n",
       " 'exists': 1071,\n",
       " 'fission': 52,\n",
       " 'yeast': 602,\n",
       " 'schizosaccharomyces': 7,\n",
       " 'pombe': 8,\n",
       " 'mammalian': 1584,\n",
       " 'genes': 7842,\n",
       " 'requires': 2891,\n",
       " '+1': 69,\n",
       " 'translational': 642,\n",
       " 'frameshift': 409,\n",
       " 'efficiency': 2868,\n",
       " 'event': 2342,\n",
       " 'reflects': 414,\n",
       " 'polyamine': 21,\n",
       " 'creating': 694,\n",
       " 'autoregulatory': 18,\n",
       " 'loop': 818,\n",
       " 'shown': 6357,\n",
       " 'newly': 2422,\n",
       " 'nematodes': 63,\n",
       " 'require': 3325,\n",
       " 'ribosomal': 626,\n",
       " 'twelve': 601,\n",
       " 'nucleotides': 854,\n",
       " 'around': 4097,\n",
       " 'identical': 995,\n",
       " 's.pombe': 1,\n",
       " 'counterparts': 304,\n",
       " 'core': 2198,\n",
       " 'element': 623,\n",
       " 'frameshifting': 713,\n",
       " 'last': 3327,\n",
       " 'ancestor': 238,\n",
       " 'mammals': 849,\n",
       " 'heterogeneous': 927,\n",
       " 'nuclear': 1587,\n",
       " 'ribonucleoprotein': 129,\n",
       " 'hnrnp': 96,\n",
       " 'a1': 236,\n",
       " 'involved': 6154,\n",
       " 'pre-mrna': 33,\n",
       " 'splicing': 261,\n",
       " 'nucleus': 506,\n",
       " 'cytoplasm': 743,\n",
       " 'demonstrate': 4701,\n",
       " 'transcription': 3210,\n",
       " 'replication': 10135,\n",
       " 'cytoplasmic': 898,\n",
       " 'mouse': 4050,\n",
       " 'hepatitis': 3992,\n",
       " 'mhv': 2369,\n",
       " 'overexpression': 605,\n",
       " 'accelerated': 533,\n",
       " 'kinetics': 755,\n",
       " 'whereas': 4926,\n",
       " 'dominant-negative': 36,\n",
       " 'mutant': 1691,\n",
       " 'lacks': 250,\n",
       " 'transport': 2125,\n",
       " 'domain': 4644,\n",
       " 'significantly': 19310,\n",
       " 'delayed': 1866,\n",
       " 'caused': 10637,\n",
       " 'global': 11496,\n",
       " 'inhibition': 3583,\n",
       " 'preferential': 157,\n",
       " 'defective-interfering': 19,\n",
       " 'rnas': 1720,\n",
       " 'wild-type': 1302,\n",
       " 'complexed': 74,\n",
       " 'polymerase': 4405,\n",
       " 'product': 1680,\n",
       " 'nucleocapsid': 1633,\n",
       " 'however': 23739,\n",
       " 'contrast': 3903,\n",
       " 'failed': 1379,\n",
       " 'bind': 1294,\n",
       " '250': 391,\n",
       " 'kda': 763,\n",
       " 'recruitment': 1042,\n",
       " 'findings': 14235,\n",
       " 'establish': 1822,\n",
       " 'factors': 15923,\n",
       " 'rna-dependent': 504,\n",
       " 'uba': 7,\n",
       " 'conserved': 2508,\n",
       " 'motif': 968,\n",
       " 'among': 20116,\n",
       " 'polyubiquitin': 46,\n",
       " 'binding': 7169,\n",
       " 'first': 19811,\n",
       " 'throughput': 365,\n",
       " 'approach': 12694,\n",
       " 'identification': 4840,\n",
       " 'domain-interacting': 1,\n",
       " 'proteome-wide': 14,\n",
       " 'perspective': 1597,\n",
       " 'rabbit': 601,\n",
       " 'reticulocyte': 47,\n",
       " 'lysate': 109,\n",
       " 'cloning': 307,\n",
       " 'successfully': 3100,\n",
       " 'eleven': 576,\n",
       " 'interact': 945,\n",
       " 'p62': 30,\n",
       " 'majority': 3442,\n",
       " 'neurodegenerative': 285,\n",
       " 'disorders': 3307,\n",
       " 'alzheimer': 241,\n",
       " 'therefore': 7666,\n",
       " 'novel': 17718,\n",
       " 'regulatory': 2017,\n",
       " 'easy': 871,\n",
       " 'route': 1493,\n",
       " 'characterization': 1750,\n",
       " 'interacting': 430,\n",
       " 'application': 4159,\n",
       " 'unfold': 50,\n",
       " 'roles': 2499,\n",
       " 'examined': 4850,\n",
       " 'microtubule': 32,\n",
       " 'cytoskeleton': 125,\n",
       " 'vaccinia': 506,\n",
       " 'found': 18704,\n",
       " 'assembled': 426,\n",
       " 'particles': 3581,\n",
       " 'accumulate': 222,\n",
       " 'vicinity': 96,\n",
       " 'microtubule-organizing': 2,\n",
       " 'centre': 915,\n",
       " 'microtubule-': 1,\n",
       " 'dynein–dynactin': 2,\n",
       " 'complex-dependent': 1,\n",
       " 'fashion': 497,\n",
       " 'microtubules': 46,\n",
       " 'intracellular': 1809,\n",
       " 'mature': 639,\n",
       " 'imv': 160,\n",
       " 'essential': 5574,\n",
       " 'enveloped': 906,\n",
       " 'iev': 10,\n",
       " 'assembly': 1321,\n",
       " 'proceeds': 77,\n",
       " 'becomes': 781,\n",
       " 'dramatically': 854,\n",
       " 'reorganized': 63,\n",
       " 'reminiscent': 97,\n",
       " 'microtubule-associated': 21,\n",
       " 'maps': 405,\n",
       " 'a10l': 2,\n",
       " 'l4r': 1,\n",
       " 'map-like': 1,\n",
       " 'mediate': 689,\n",
       " 'direct': 4991,\n",
       " 'cores': 94,\n",
       " 'severe': 29168,\n",
       " 'reduction': 5843,\n",
       " 'centrosome': 7,\n",
       " 'loss': 6218,\n",
       " 'centrosomal': 1,\n",
       " 'nucleation': 20,\n",
       " 'represents': 1973,\n",
       " 'example': 1901,\n",
       " 'viral-induced': 113,\n",
       " 'disruption': 1018,\n",
       " 'provide': 13828,\n",
       " 'insights': 2180,\n",
       " 'nan': 41830,\n",
       " 'hundreds': 424,\n",
       " 'infect': 1487,\n",
       " 'organs': 1467,\n",
       " 'fatal': 1905,\n",
       " 'emerging': 6594,\n",
       " 'become': 4692,\n",
       " 'serious': 3434,\n",
       " 'worldwide': 6449,\n",
       " 'diagnosis': 12397,\n",
       " 'subsequent': 3041,\n",
       " 'treatment': 35859,\n",
       " 'fighting': 321,\n",
       " 'diagnostic': 8383,\n",
       " 'frequently': 3736,\n",
       " 'employ': 380,\n",
       " '-based': 272,\n",
       " 'quickly': 1463,\n",
       " 'detect': 3888,\n",
       " 'pathogenic': 3230,\n",
       " 'etiology': 1761,\n",
       " 'illness': 6834,\n",
       " 'fast': 1440,\n",
       " 'method': 11633,\n",
       " 'suffers': 64,\n",
       " 'drawbacks': 155,\n",
       " 'false-positive': 188,\n",
       " 'ability': 5020,\n",
       " 'targets': 3281,\n",
       " 'microarray': 815,\n",
       " 'technology': 3971,\n",
       " 'solves': 20,\n",
       " 'problems': 2973,\n",
       " 'limitations': 2217,\n",
       " 'effectively': 2358,\n",
       " 'applied': 5043,\n",
       " 'fields': 872,\n",
       " 'molecular': 9205,\n",
       " 'recently': 5882,\n",
       " 'retrovirology': 3,\n",
       " 'described': 5597,\n",
       " 'multi-virus': 5,\n",
       " 'dna': 6198,\n",
       " 'contains': 2697,\n",
       " 'open': 5390,\n",
       " 'reading': 1261,\n",
       " 'frames': 564,\n",
       " 'eight': 2862,\n",
       " 'immunodeficiency': 1334,\n",
       " 'type': 11395,\n",
       " '1.': 617,\n",
       " 'co-infections': 455,\n",
       " 'benefit': 2913,\n",
       " 'kind': 417,\n",
       " 'studying': 856,\n",
       " 'promoter': 896,\n",
       " 'correlating': 100,\n",
       " 'readouts': 40,\n",
       " 'progression': 3273,\n",
       " 'reactivation': 320,\n",
       " 'latent': 571,\n",
       " 'thus': 7704,\n",
       " 'dna-chip': 1,\n",
       " 'reported': 17202,\n",
       " 'advance': 784,\n",
       " 'could': 17353,\n",
       " 'tool': 4403,\n",
       " 'characterizing': 319,\n",
       " 'aids': 705,\n",
       " 'well': 17690,\n",
       " 'introduction': 4544,\n",
       " 'pathogenicity': 1117,\n",
       " 'late': 2851,\n",
       " 'herpes': 794,\n",
       " 'simplex': 536,\n",
       " '1': 25950,\n",
       " 'hsv-1': 477,\n",
       " 'unclear': 2250,\n",
       " 'four': 8847,\n",
       " 'persistent': 1796,\n",
       " 'infiltrates': 466,\n",
       " 'unknown': 3878,\n",
       " 'origin': 2252,\n",
       " 'isolation': 4941,\n",
       " 'tracheal': 1282,\n",
       " 'aspirate': 317,\n",
       " 'bronchoalveolar': 624,\n",
       " 'lavage': 831,\n",
       " 'fluid': 3273,\n",
       " '1–11': 5,\n",
       " 'days': 20024,\n",
       " 'start': 1064,\n",
       " 'mechanical': 4329,\n",
       " 'ventilatory': 485,\n",
       " 'leak': 1037,\n",
       " 'index': 5453,\n",
       " 'pli': 22,\n",
       " '67': 1087,\n",
       " 'gallium': 9,\n",
       " 'ga': 540,\n",
       " '-transferrin': 1,\n",
       " 'limit': 2199,\n",
       " '14.1': 112,\n",
       " '×': 1661,\n",
       " '10': 13130,\n",
       " '-3': 152,\n",
       " '/min': 23,\n",
       " 'measured': 4956,\n",
       " 'ranged': 1463,\n",
       " '7.5': 442,\n",
       " '14.0': 106,\n",
       " 'course': 4563,\n",
       " 'acyclovir': 78,\n",
       " 'survived': 552,\n",
       " 'conclusions': 18836,\n",
       " 'capillary': 325,\n",
       " 'permeability': 382,\n",
       " 'observed': 13644,\n",
       " 'argues': 220,\n",
       " 'favors': 58,\n",
       " 'immunodepresssion': 1,\n",
       " 'rather': 2183,\n",
       " 'superimposed': 91,\n",
       " 'background': 20175,\n",
       " 'previous': 5170,\n",
       " 'smallpox': 358,\n",
       " 'ring': 433,\n",
       " 'vaccination': 5137,\n",
       " 'based': 17378,\n",
       " 'contact': 6337,\n",
       " 'tracing': 1325,\n",
       " 'network': 4551,\n",
       " 'suggest': 8757,\n",
       " 'effective': 14154,\n",
       " 'explicitly': 219,\n",
       " 'included': 14585,\n",
       " 'logistics': 199,\n",
       " 'limited': 7404,\n",
       " 'numbers': 2929,\n",
       " 'vaccinators': 2,\n",
       " 'developed': 12935,\n",
       " 'continuous-time': 28,\n",
       " 'stochastic': 626,\n",
       " 'simulation': 1640,\n",
       " 'transmission': 15551,\n",
       " 'structure': 6079,\n",
       " 'post-exposure': 148,\n",
       " 'contacts': 2212,\n",
       " 'capacity': 4170,\n",
       " 'heterogeneity': 1484,\n",
       " ...}"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "freqTable"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Sorting frequency table in decsending order\n",
    "sort_orders = sorted(freqTable.items(), key=lambda x: x[1], reverse=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('patients', 131641),\n",
       " ('covid-19', 80271),\n",
       " ('virus', 62451),\n",
       " ('disease', 59064),\n",
       " ('results', 58843)]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Top 5 from frquency table\n",
    "sort_orders[:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Get top 30 from freq table\n",
    "top30counts = sort_orders[:30]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 576x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "#Creating Plot for words in Abstracts\n",
    "\n",
    "labels, values = zip(*top30counts)\n",
    "fig, ax = plt.subplots(figsize=(8, 8))\n",
    "ypos = np.arange(len(labels)) \n",
    "ax.barh(ypos, values,align = \"center\", color = \"purple\")\n",
    "\n",
    "\n",
    "ax.set_yticks(ypos)\n",
    "ax.set_yticklabels(labels)\n",
    "ax.invert_yaxis()  # labels read top-to-bottom\n",
    "ax.set_xlabel('Count')\n",
    "ax.set_title('Most Common Words in Abstracts (Top 30)')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
